Empowered Patient Podcast

Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from this rare disease, Jill has created five closed Facebook groups to support men, women, and family and loved ones who are affected by acromegaly. #acromegaly #pituitary #raredisease #PatientAdvocate #PatientAdvocacy Acromegalycommunity.org Download the transcript here

Dr. John Poothullil, is an expert on diabetes and cancer as well as an author.  He talks about his newest book When Your Child Has Cancer and what we have learned about the causes and possible treatments for cancers that strike children.  With an eye to improving the immune system of the child, Dr. John reminds us that precancerous and cancer cells often are found in the body but the immune system is designed to destroy them.  He also provides tips for caregivers of children with cancer to empower all to join in the fight for recovery. #cancer #childhoodcancer #childhoodcancerawareness DrJohnHealth.com Download the transcript here

Jim Archetto, Vice President Gaumard Scientific describes the range of simulators available to train healthcare professionals in routine medical procedures as well as rarely seen scenarios.  Simulation becomes vital in the education process during these days of COVID-19. Life-like patient simulators are being used to train physicians and nurses to insert an IV, deliver babies, treat newborns, and respond to adult critical care needs. These medical robots are changing the face of healthcare education. @GaumardinFocus  #COVID19 #medicalrobots #medicalsimulators Gaumard.com Download the transcript here.  

Craig Fraser, CEO and President, Windtree Therapeutics talks about acute heart failure, the number one reason for hospitalization in people over 65 and the fact that there has been little innovation in trying to improve cardiac function. Developing a novel dual action drug called istaroxime, Windtree is addressing both parts of the cycles of the heart - increasing blood pressure and also lowering the heart rate. After using a diuretic, administration of ista is producing positive data for better function of the heart. @windtreetx #AHF #HeartFailure #cardiovascular Windtreetx.com Download the transcript here

Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the needs revealed by the COVID-19 pandemic as well as the ability of international investors, scientists, and pharma and biotech experts to participate online.  The key mission is to drive collaboration and funding for the next generation of medical therapies. @HTID_Paris #HTID #healthtechforcare #innovation #conference HTID-Paris.com Download the transcript here.

Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company's founding scientist, Professor Sir David Lane, the mission of Cyclacel is to provide cancer patients with a treatment that allows them to live with their cancer and not die from it. #Cyclacel #fadra #cancer #solidtumors Cyclacel.com Download the transcript here  

Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium, the muscle of the heart. With their interventional cardiology procedure, the implanted device increases the pressure inside these small arteries and  improves all symptoms.   @neovasc #RefractoryAngina #angina #heartdisease Neovasc.com Download the transcript here

Brian Culley, CEO, Lineage Cell Therapeutics talks about the risk we all face from developing age-related macular degeneration - both wet AMD and dry AMD. While there are treatments for wet AMD, currently there is no interventional approved treatment for dry AMD. Lineage is developing a ground-breaking treatment for dry AMD that includes injecting new retina cells into the back of the eye which then multiply and repair and even reverse the damage to the eye. @LineageCell #AMD #WetAMD #DryAMD #eyehealth #celltherapy LineageCell.com Download the transcript here.  

Omri Shor, CEO and co-founder, Medisafe talks about the different aspects of medication adherence and challenges faced by patients trying to maintain their drug therapy schedules. With an eye towards personalized medicine, Medisafe strives to build bridges and integrate healthcare services for patients to allow them to better track and manage their health particularly In the age of COVID-19 when patients as well as caregivers are facing new challenges. While being HIPAA and GDPR compliant, Medisafe can also provide valuable information to drug manufacturers and doctors about common barriers to drug adherence. @medisafeapp #precisionsmedicine #medicationadherence #COVID19 Medisafe.com Download the the transcript here.  

Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies.  Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly injectable dominated market. Their proprietary delivery technology solves the problem of getting peptides through the stomach and delivering the medication to the intestine. Chiasma is excited about the potential of MYCAPSSA being a new standard of pharmacological care. #acromegaly #raredisease #ChronicDisorder #biotechnews Chiasma.com Download the transcript here